🔥 Premium AI-powered Stock Picks from InvestingPro Now up to 50% OffCLAIM SALE

Healthcare payments firm Waystar's shares slip in Nasdaq debut

Published 06/07/2024, 01:42 PM
Updated 06/07/2024, 04:46 PM
© Reuters. The Nasdaq Market site is seen on the day that shares of Truth Social and Trump Media & Technology Group start trading under the ticker "DJT", outside the Nasdaq Market site in New York City, U.S., March 26, 2024.  REUTERS/Brendan McDermid/File Photo

By Arasu Kannagi Basil and Echo Wang

(Reuters) -Waystar's shares fell in their Nasdaq debut on Friday, after the healthcare payments company raised $968 million in its U.S. initial public offering, in what was one of the largest deals of the year.

The company's stock opened at $21, slightly below the IPO price of $21.50, giving it a valuation of $3.50 billion. The stock traded as high as the IPO price earlier in the session before closing at $20.70.

Waystar, backed by Swedish private equity firm EQT AB (ST:EQTAB) and Canadian pension fund giant CPPIB, sold 45 million shares in the offering.

The progress in Waystar's IPO shows the market for new listings remains open after aluminium recycler Novelis pulled its stock market debut that would have raised as much as $945 million earlier this week.

The company, formed in 2017 through the merger of Navicure and ZirMed, develops payments software that helps clients like large hospital systems collect bills from patients.

EQT and CPPIB acquired a majority stake in Waystar from alternative investment firm Bain Capital in 2019, valuing the company at $2.7 billion. Bain stayed on as a minority shareholder.

Investment management firm Neuberger Berman and sovereign wealth fund Qatar Investment Authority had indicated an interest in buying up to $225 million worth of shares in the IPO.

PARING DOWN DEBT

Under EQT and CPPIB's ownership, Waystar has gained scale by acquiring some of its rivals, including eSolutions in 2020, which boosted its presence in the lucrative government health insurance market for the elderly, known as Medicare.

Waystar intends to use the IPO proceeds to repay outstanding debt.

© Reuters. The Nasdaq Market site is seen on the day that shares of Truth Social and Trump Media & Technology Group start trading under the ticker

“We are using the proceeds of the IPO to reduce our leverage, exposure and improve our capital structure and really position the company effectively for that durable long term path of continuing to transform a healthcare industry,” Waystar CEO Matt Hawkins (NASDAQ:HWKN) told Reuters in an interview.

Goldman Sachs, J.P. Morgan Securities and Barclays Capital were the lead underwriters for the IPO.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.